Cyclothiazomycin C
| Internal ID | 2f22eaab-638e-4f94-b60d-e869ab138950 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Cyclic peptides |
| IUPAC Name | (12R,27S,30R,33S,36S,48S,51R,55S,59R,62Z)-36-(4-aminobutyl)-55-(2-amino-2-oxoethyl)-62-ethylidene-33,51-dimethyl-15,42-dimethylidene-13,28,34,37,40,43,49,53,60,63-decaoxo-6,10,17,21,25,32,57-heptathia-14,29,35,38,41,44,50,54,61,64,65,66,67,68,69,70,71-heptadecazadecacyclo[31.19.12.14,52.15,8.19,12.116,19.120,23.124,27.156,59.044,48]henheptaconta-1(52),2,4(66),5(71),7,9(70),16(69),18,20(68),22,24(67),56(65)-dodecaene-30-carboxylic acid |
| SMILES (Canonical) | CC=C1C(=O)NC2(C(=O)NC(C(=O)NCC(=O)NC(=C)C(=O)N3CCCC3C(=O)NC(C4=C(C=CC(=N4)C5=NC(=CS5)C6=NC(CS6)C(=O)NC(=C)C7=NC(=CS7)C8=NC(=CS8)C9=NC(CS9)C(=O)NC(CS2)C(=O)O)C(=O)NC(C2=NC(CS2)C(=O)N1)CC(=O)N)C)CCCCN)C |
| SMILES (Isomeric) | C/C=C\1/C(=O)N[C@@]2(C(=O)N[C@H](C(=O)NCC(=O)NC(=C)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C4=C(C=CC(=N4)C5=NC(=CS5)C6=N[C@@H](CS6)C(=O)NC(=C)C7=NC(=CS7)C8=NC(=CS8)C9=N[C@H](CS9)C(=O)N[C@@H](CS2)C(=O)O)C(=O)N[C@H](C2=N[C@@H](CS2)C(=O)N1)CC(=O)N)C)CCCCN)C |
| InChI | InChI=1S/C60H67N19O13S7/c1-6-29-49(87)78-60(5)59(92)77-30(10-7-8-14-61)45(83)63-17-42(81)64-27(4)57(89)79-15-9-11-40(79)50(88)65-25(2)43-28(44(82)69-32(16-41(62)80)53-71-34(19-94-53)47(85)68-29)12-13-31(67-43)52-75-37(22-97-52)54-72-33(18-95-54)46(84)66-26(3)51-74-36(21-93-51)56-76-38(23-98-56)55-73-35(20-96-55)48(86)70-39(24-99-60)58(90)91/h6,12-13,21-23,25,30,32-35,39-40H,3-4,7-11,14-20,24,61H2,1-2,5H3,(H2,62,80)(H,63,83)(H,64,81)(H,65,88)(H,66,84)(H,68,85)(H,69,82)(H,70,86)(H,77,92)(H,78,87)(H,90,91)/b29-6-/t25-,30+,32+,33+,34+,35-,39+,40+,60+/m1/s1 |
| InChI Key | ZUDMXUJOZNUCIR-XRARMUINSA-N |
| Popularity | 1 reference in papers |
| Molecular Formula | C60H67N19O13S7 |
| Molecular Weight | 1486.80 g/mol |
| Exact Mass | 1485.3210715 g/mol |
| Topological Polar Surface Area (TPSA) | 663.00 Ų |
| XlogP | -2.20 |
| Atomic LogP (AlogP) | 0.49 |
| H-Bond Acceptor | 27 |
| H-Bond Donor | 12 |
| Rotatable Bonds | 7 |
| RefChem:130014 |
| (12R,27S,30R,33S,36S,48S,51R,55S,59R,62Z)-36-(4-aminobutyl)-55-(2-amino-2-oxoethyl)-62-ethylidene-33,51-dimethyl-15,42-dimethylidene-13,28,34,37,40,43,49,53,60,63-decaoxo-6,10,17,21,25,32,57-heptathia-14,29,35,38,41,44,50,54,61,64,65,66,67,68,69,70,71-heptadecazadecacyclo(31.19.12.14,52.15,8.19,12.116,19.120,23.124,27.156,59.044,48)henheptaconta-1(52),2,4(66),5(71),7,9(70),16(69),18,20(68),22,24(67),56(65)-dodecaene-30-carboxylic acid |
| SCHEMBL19228587 |
| SCHEMBL29909740 |
| CHEBI:222068 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.7825 | 78.25% |
| Caco-2 | - | 0.8611 | 86.11% |
| Blood Brain Barrier | - | 0.9250 | 92.50% |
| Human oral bioavailability | - | 0.5286 | 52.86% |
| Subcellular localzation | Mitochondria | 0.5415 | 54.15% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8024 | 80.24% |
| OATP1B3 inhibitior | + | 0.9261 | 92.61% |
| MATE1 inhibitior | - | 0.9000 | 90.00% |
| OCT2 inhibitior | - | 0.8500 | 85.00% |
| BSEP inhibitior | + | 0.9649 | 96.49% |
| P-glycoprotein inhibitior | + | 0.7424 | 74.24% |
| P-glycoprotein substrate | + | 0.8773 | 87.73% |
| CYP3A4 substrate | + | 0.7530 | 75.30% |
| CYP2C9 substrate | - | 0.8064 | 80.64% |
| CYP2D6 substrate | - | 0.8619 | 86.19% |
| CYP3A4 inhibition | - | 0.9323 | 93.23% |
| CYP2C9 inhibition | - | 0.8285 | 82.85% |
| CYP2C19 inhibition | - | 0.8052 | 80.52% |
| CYP2D6 inhibition | - | 0.9123 | 91.23% |
| CYP1A2 inhibition | - | 0.7687 | 76.87% |
| CYP2C8 inhibition | + | 0.8611 | 86.11% |
| CYP inhibitory promiscuity | - | 0.9461 | 94.61% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.9200 | 92.00% |
| Carcinogenicity (trinary) | Non-required | 0.6008 | 60.08% |
| Eye corrosion | - | 0.9838 | 98.38% |
| Eye irritation | - | 0.8957 | 89.57% |
| Skin irritation | - | 0.7521 | 75.21% |
| Skin corrosion | - | 0.9171 | 91.71% |
| Ames mutagenesis | + | 0.5800 | 58.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7047 | 70.47% |
| Micronuclear | + | 0.8300 | 83.00% |
| Hepatotoxicity | - | 0.5789 | 57.89% |
| skin sensitisation | - | 0.8256 | 82.56% |
| Respiratory toxicity | + | 0.8444 | 84.44% |
| Reproductive toxicity | + | 0.9222 | 92.22% |
| Mitochondrial toxicity | + | 0.9000 | 90.00% |
| Nephrotoxicity | - | 0.7464 | 74.64% |
| Acute Oral Toxicity (c) | III | 0.5705 | 57.05% |
| Estrogen receptor binding | - | 0.5000 | 50.00% |
| Androgen receptor binding | + | 0.7768 | 77.68% |
| Thyroid receptor binding | + | 0.7583 | 75.83% |
| Glucocorticoid receptor binding | + | 0.7936 | 79.36% |
| Aromatase binding | + | 0.7887 | 78.87% |
| PPAR gamma | + | 0.7561 | 75.61% |
| Honey bee toxicity | - | 0.6385 | 63.85% |
| Biodegradation | - | 0.9000 | 90.00% |
| Crustacea aquatic toxicity | - | 0.5100 | 51.00% |
| Fish aquatic toxicity | + | 0.9588 | 95.88% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.09% | 96.09% |
| CHEMBL2093869 | P05106 | Integrin alpha-IIb/beta-3 | 98.68% | 95.42% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 98.41% | 93.03% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.54% | 91.11% |
| CHEMBL2243 | O00519 | Anandamide amidohydrolase | 97.45% | 97.53% |
| CHEMBL2581 | P07339 | Cathepsin D | 97.37% | 98.95% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 97.00% | 86.33% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 96.63% | 92.97% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 96.58% | 93.00% |
| CHEMBL3012 | Q13946 | Phosphodiesterase 7A | 95.91% | 99.29% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 95.67% | 95.56% |
| CHEMBL241 | Q14432 | Phosphodiesterase 3A | 94.75% | 92.94% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 94.15% | 95.89% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 94.13% | 83.82% |
| CHEMBL284 | P27487 | Dipeptidyl peptidase IV | 94.11% | 95.69% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 93.97% | 90.17% |
| CHEMBL325 | Q13547 | Histone deacetylase 1 | 93.87% | 95.92% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 93.67% | 80.71% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 93.28% | 94.45% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 91.51% | 94.75% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 91.08% | 99.23% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 90.88% | 90.08% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 90.51% | 90.71% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 88.80% | 97.64% |
| CHEMBL3038469 | P24941 | CDK2/Cyclin A | 88.35% | 91.38% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 88.13% | 97.09% |
| CHEMBL1628481 | P35414 | Apelin receptor | 87.69% | 97.89% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 87.05% | 97.25% |
| CHEMBL2443 | P49862 | Kallikrein 7 | 86.28% | 94.00% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 86.13% | 85.14% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 85.90% | 96.90% |
| CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 85.47% | 91.24% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 85.36% | 100.00% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 84.94% | 88.56% |
| CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 84.90% | 91.71% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 83.96% | 95.56% |
| CHEMBL1293255 | P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD+] | 83.39% | 83.57% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 82.49% | 90.24% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 81.75% | 98.33% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 81.21% | 82.38% |
| CHEMBL4530 | P00488 | Coagulation factor XIII | 81.09% | 96.00% |
| CHEMBL1902 | P62942 | FK506-binding protein 1A | 80.84% | 97.05% |
| CHEMBL4895 | P30530 | Tyrosine-protein kinase receptor UFO | 80.59% | 90.95% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 130317475 |
| LOTUS | LTS0006871 |
| wikiData | Q105383520 |